<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.895302</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20250107144055</marc:controlfield>
    <marc:controlfield tag="006">m     o  d f      </marc:controlfield>
    <marc:controlfield tag="007">cr |n|||||||||</marc:controlfield>
    <marc:controlfield tag="008">210114s1965    onc     obs  f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
      <marc:subfield code="e">rda</marc:subfield>
      <marc:subfield code="c">CaOODSP</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1=" " ind2=" ">
      <marc:subfield code="a">Z1-1961/3-1-7E-PDF</marc:subfield>
      <marc:subfield code="z">Z1-1961/3-1/7</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="110" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.‏ ‎</marc:subfield>
      <marc:subfield code="b">Department of National Health and Welfare.‏ </marc:subfield>
      <marc:subfield code="b">Research and Statistics Division, </marc:subfield>
      <marc:subfield code="e">author.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Provision, distribution, and cost of drugs in Canada / </marc:subfield>
      <marc:subfield code="c">Research and Statistics Division, Department of National Health and Welfare.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">Ottawa, Canada : </marc:subfield>
      <marc:subfield code="b">Roger Duhamel, Queen's Printer and Controller of Stationery, </marc:subfield>
      <marc:subfield code="c">1965.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (viii, 128 pages)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Digitized edition from print [produced by Privy Council Office].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographical references.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="505" ind1="0" ind2=" ">
      <marc:subfield code="a">Foreword -- List of Tables -- Introduction -- Background of Canadian Pharmacy -- Present Methods of Production and Distribution of Drugs in Canada -- Expenditure on Drugs in Canada -- Pharmaceutical Benefits for Recipients of Organized Public Assistance Programs in Canada -- Voluntary Prepayment Plans -- Provision of Drugs Under Health Insurance Programs in Various Countries -- Appendix.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"During the past four years the entire spectrum of costs, profits and prices of drugs has been intensively discussed by the Canadian public. The first formal investigation of recent importance on this continent was that undertaken in the United States by the Senate Subcommittee on Antitrust and Monopoly (the Kefauver Committee). This committee's inquiry was followed in Canada by the investigation on the manufacture, distribution and sale of drugs undertaken by the Director of Investigation and Research under the Combines Investigation Act. His study was, in turn, followed by hearings initiated by the Federal Restrictive Trade Practices Commission to ascertain whether or not price-fixing of drugs exists at any, or all three, of the manufacturing, distributing and retailing levels. The primary aim has been to include constructive and factual information derived from objective evidence within the Canadian context"--Introduction.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Pharmaceutical industry</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Drugs</marc:subfield>
      <marc:subfield code="x">Prices</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="6">
      <marc:subfield code="a">Industrie pharmaceutique</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="6">
      <marc:subfield code="a">Médicaments</marc:subfield>
      <marc:subfield code="x">Prix</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="655" ind1=" " ind2="7">
      <marc:subfield code="a">Statistics</marc:subfield>
      <marc:subfield code="2">lcgft</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="655" ind1=" " ind2="7">
      <marc:subfield code="a">Statistiques</marc:subfield>
      <marc:subfield code="2">rvmgf</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Royal Commission on Health Services, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">53.07 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2021/bcp-pco/Z1-1961-3-1/Z1-1961-3-1-7-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
